Gartan Parveen, Brooks Charles L, Reuter Nathalie
Department of Chemistry, University of Bergen, Bergen 5020, Norway.
Computational Biology Unit, University of Bergen, Bergen 5020, Norway.
J Chem Inf Model. 2025 Jul 14;65(13):6835-6846. doi: 10.1021/acs.jcim.5c00320. Epub 2025 Jun 16.
In structure-based drug discovery, reliable structural models of ligands bound to their target receptors are critical for establishing the structure-activity relationship of the congeneric series. In such a series, substitutions on a common scaffold core might lead to different binding modes, ranging from slight changes of orientations to flipping or inversion of the core structure. Moreover, molecular docking might lead to alternative orientations within the top-ranked poses without being able to discriminate which is most likely. To determine the relative binding affinities between two alternative ligand poses, we propose a methodology based on relative binding free energy calculations using the λ-dynamics method. We used a dual-topology approach with distance-restraining schemes. We introduced a novel strategy using a one-step perturbation to calculate the contributions of the applied restraints. While using FEP/MBAR instead for that purpose led to smaller uncertainties, it suffered from convergence issues. We tested the validity and predictive power of our approach using two pharmaceutically relevant targets and eight small-molecule inhibitors from the experimentally characterized congeneric series. For each target, our approach correctly ranks the known X-ray poses as more favorable than alternative flipped poses. The proposed methodology can be easily extended to rank more than two poses and should also be applicable to the evaluation of alternative rotamers of target amino acids.
在基于结构的药物发现中,与靶标受体结合的配体的可靠结构模型对于建立同系物系列的构效关系至关重要。在这样的系列中,常见支架核心上的取代可能导致不同的结合模式,从方向的轻微变化到核心结构的翻转或反转。此外,分子对接可能会在排名靠前的构象中产生替代方向,而无法区分哪一个最有可能。为了确定两种替代配体构象之间的相对结合亲和力,我们提出了一种基于使用λ动力学方法进行相对结合自由能计算的方法。我们使用了一种带有距离限制方案的双拓扑方法。我们引入了一种使用一步扰动来计算所施加限制贡献的新策略。虽然为此目的改用FEP/MBAR会导致较小的不确定性,但它存在收敛问题。我们使用两个与药物相关的靶标和来自实验表征的同系物系列的八种小分子抑制剂测试了我们方法的有效性和预测能力。对于每个靶标,我们的方法正确地将已知的X射线构象排名为比替代的翻转构象更有利。所提出的方法可以很容易地扩展到对两个以上的构象进行排名,并且也应该适用于评估靶标氨基酸的替代旋转异构体。